US 12,480,168 B2
Detection methods
Danny Filer, Bristol (GB); Claire Ferrao, Trowbridge (GB); and Sharon Chadwick, Trowbridge (GB)
Assigned to Binx Health Limited, Trowbridge (GB)
Filed by Binx Health Limited, Trowbridge (GB)
Filed on Apr. 2, 2024, as Appl. No. 18/624,594.
Application 18/624,594 is a continuation of application No. 17/587,530, filed on Jan. 28, 2022, granted, now 11,976,336.
Application 17/587,530 is a continuation of application No. 16/683,897, filed on Nov. 14, 2019, granted, now 11,261,501, issued on Mar. 1, 2022.
Application 16/683,897 is a continuation of application No. 15/511,893, granted, now 10,519,514, issued on Dec. 31, 2019, previously published as PCT/GB2015/052693, filed on Sep. 17, 2015.
Claims priority of application No. 1416459 (GB), filed on Sep. 17, 2014.
Prior Publication US 2025/0051859 A1, Feb. 13, 2025
Int. Cl. C12Q 1/689 (2018.01)
CPC C12Q 1/689 (2013.01) [C12Q 2600/158 (2013.01); C12Q 2600/16 (2013.01)] 12 Claims
 
1. A detection cartridge comprising:
reagents for extraction of nucleic acid from a sample;
primers that amplify genetic targets from C. trachomatis and T. vaginalis to yield amplicons; and
nucleic acid probes that hybridize to the amplicons, the nucleic acid probes including a label that signals when the nucleic acid probes are hybridized to the amplicons,
wherein the primers comprise a set of forward primers comprising 12 or more contiguous nucleotides within SEQ ID NO: 18 and 12 or more contiguous nucleotides within SEQ ID NO: 23.